Alexander Bautista, MD
Pain Medicine · Sellersburg, INNPI 1073754321
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 13.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,915, 5.8 times the $329 reported in 2019.
Across 157 payments — averaging $49.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Abbott$1K
- Boston Scientific$777
- Nevro Corp.$656
- Averitas Pharma Inc.$420
- Avanos Medical$387
- plus $3K from 33 others
What the payments were for
- Travel & lodging$1071%
- Food & beverage$7,54998%
- Education$721%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 19 | $1,066 |
| Abbott | 17 | $1,022 |
| Boston Scientific | 11 | $777 |
| Nevro Corp. | 15 | $656 |
| Averitas Pharma Inc. | 4 | $420 |
| Avanos Medical | 7 | $387 |
| Pacira Pharmaceuticals Incorporated | 4 | $381 |
| Si-bone, Inc. | 9 | $378 |
| Collegium Pharmaceutical, Inc. | 12 | $245 |
| Curonix LLC | 2 | $240 |
| Saluda Medical Americas, Inc. | 5 | $228 |
| Tersera Therapeutics LLC | 3 | $171 |
| Vertex | 3 | $170 |
| BD | 1 | $160 |
| SPR Therapeutics, Inc | 3 | $158 |
| Trevena, Inc. | 3 | $130 |
| Tonix Medicines, Inc. | 2 | $111 |
| AbbVie(2 entities) | 2 | $111 |
| Globus Medical | 2 | $99 |
| Spinal Simplicity, LLC | 1 | $99 |
| Stratus Medical, LLC | 2 | $97 |
| Bayer | 5 | $81 |
| Heron Therapeutics, Inc. | 1 | $81 |
| GE HealthCare | 2 | $54 |
| Scilex Pharmaceuticals Inc. | 3 | $53 |
| Smith+Nephew | 2 | $44 |
| Fisher & Paykel Healthcare Inc | 1 | $41 |
| Amgen | 3 | $40 |
| GRT US Holding, Inc. | 2 | $38 |
| Merck | 2 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Insulet Corporation | 1 | $22 |
| Lifescan, Inc. | 1 | $21 |
| Nalu Medical, Inc. | 1 | $21 |
| Biotronik NRO, Inc. | 1 | $19 |
| Haemonetics Corporation | 1 | $18 |
| Covidien LP | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Stimwave Technologies Incorporated | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$419
- Qutenza$383
- EXPAREL$364
- GENERATOR$234
- ETERNA$194
- Proclaim Family of SCS IPGs$177
- SYNCHROMEDII$166
- HemoSphere$160
- Proclaim IPG$148
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$142
- Senza Spinal Cord Stimulation System$139
- BIS$131
- PRIALT$127
- Omnia$125
- Evoke SCS$120
- GENERAL PAIN MANAGEMENT$116
- SPECTRA WAVEWRITER$114
- PROCLAIM$113
How this compares
$7,729 in reported general payments places this provider in the 70th percentile of 128 pain medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 12 | $42,763 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,104 | $32,278 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,273 | $27,002 |
| Gabapentin | 1,447 | $19,811 |
| OxycontinOxycodone Hcl | 29 | $18,933 |
| Xtampza ErOxycodone Myristate | 32 | $18,185 |
| Pregabalin | 414 | $12,089 |
| Tizanidine Hcl | 1,016 | $10,580 |
| BelbucaBuprenorphine Hcl | 24 | $10,303 |
| Oxycodone Hcl | 268 | $9,353 |
| Hydromorphone Hcl | 58 | $3,305 |
| Fentanyl | 50 | $3,127 |
| Duloxetine Hcl | 146 | $3,027 |
| Amitriptyline Hcl | 210 | $1,985 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 64 | $1,772 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GRT US Holding, Inc.Qutenza | $38 | $42,76312 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $245 | $28,48856 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 128 pain medicine providers in Indiana.
Other pain medicine in Sellersburg
- Derron WilsonCarmel$616K
- Kevin MacadaegCarmel$337K
- Andrew TrobridgeMuncie$253K
- Meredith LanghorstFishers$233K
- Abhishek DasMishawaka$186K
- Rajiv TewariFishers$140K
- John SwoffordIndianapolis$127K
- Neal ColemanMuncie$38K
- Matthew DevriesLafayette$37K
- Amer KaziGranger$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.